Heart disease remains one of the biggest health threats in the world. Every year, it causes about 20 million deaths globally.
In the United Kingdom alone, heart disease accounts for roughly one quarter of all deaths. Conditions such as heart attacks and strokes often develop when fatty substances build up inside blood vessels, making it harder for blood to flow properly through the body.
One of the most widely used treatments to reduce this risk is a group of medicines called statins. Statins help lower levels of LDL cholesterol, often called “bad cholesterol.”
When LDL cholesterol builds up in the arteries, it can form plaques that narrow or block blood vessels. Over time, this process can lead to serious problems such as heart attacks, strokes, and other cardiovascular diseases.
Because of their ability to reduce cholesterol and protect the heart, statins have become one of the most commonly prescribed medications in the world. Hundreds of millions of people have taken them over the past three decades.
Large medical studies have shown that statins can significantly reduce the risk of heart attacks and strokes, especially in people who already have heart disease or are at high risk.
Despite these benefits, some patients are hesitant to take statins. Many people worry about possible side effects they have heard about in the media or read in medication leaflets. Concerns about muscle pain, memory problems, liver damage, or other health issues have led some patients to stop taking the medication or avoid it altogether.
To better understand whether these concerns are supported by scientific evidence, researchers carried out a large analysis of clinical trials involving statins. The research was conducted by the Cholesterol Treatment Trialists’ Collaboration, a global group of scientists who study cholesterol-lowering treatments.
The study brought together data from 23 major randomized clinical trials. These trials involved more than 150,000 participants in total.
Nineteen of the trials compared people taking statins with people taking a placebo, which is a dummy pill that has no active medicine. Four additional trials compared people taking higher-intensity statin therapy with those receiving less intensive treatment.
Randomized clinical trials are considered one of the most reliable ways to study medicines. In these trials, participants are randomly assigned to different groups, and neither the participants nor the researchers know who receives the real drug or the placebo. This design helps reduce bias and makes it easier to identify true effects of a medication.
The researchers carefully reviewed reports of possible side effects during the studies. Surprisingly, they found that most symptoms occurred at almost the same rate in people taking statins and people taking placebo pills.
For example, reports of memory or thinking problems were extremely rare and occurred equally in both groups. About 0.2 percent of participants reported such symptoms each year whether they were taking statins or not. This suggests that statins themselves are unlikely to be the cause.
Across nearly all of the conditions listed as potential side effects in medication leaflets, the researchers found no clear increase in risk linked to statin use. These included concerns such as depression, sleep problems, erectile dysfunction, headaches, nausea, fatigue, and weight gain.
One small difference did appear in liver blood test results. People taking statins had about a 0.1 percent higher chance of having abnormal liver enzyme levels. However, these mild changes did not lead to higher rates of serious liver diseases such as hepatitis or liver failure. In most cases, the abnormal test results did not cause long-term health problems.
Earlier research from the same group had already examined muscle symptoms, which are among the most common concerns about statins. The studies showed that only about 1 percent of patients experienced muscle problems that were actually caused by statins during the first year of treatment. After the first year, there was no additional increase in risk.
The researchers also confirmed that statins can slightly raise blood sugar levels. Because of this effect, people who are already at high risk of diabetes may develop the condition slightly earlier. However, experts say that the benefits of statins in preventing heart attacks and strokes usually outweigh this small risk.
The study was led by researchers from Oxford Population Health and involved scientists from many countries. The results provide strong evidence that many widely discussed statin side effects may not actually be caused by the medication.
The findings also suggest that the warning labels on statin medicines may need to be reconsidered. Many of the listed side effects were originally based on observational studies rather than randomized trials. Observational studies can sometimes be influenced by other factors, making it difficult to determine whether a medication truly causes a symptom.
By combining evidence from large randomized trials, the researchers were able to provide a clearer and more reliable picture of statin safety.
When reviewing the findings, it is important to remember that no medication is completely free of side effects. However, the evidence suggests that statins are generally much safer than many people believe. For most patients who are at risk of cardiovascular disease, the protective benefits of statins greatly outweigh the small chance of side effects.
The study highlights an important issue in modern medicine: misinformation about drug safety can discourage people from taking treatments that could save their lives. If patients stop taking statins because of fears that are not supported by strong evidence, they may face a higher risk of heart attacks or strokes.
Overall, this research provides reassurance for both doctors and patients. Statins remain one of the most effective tools available for preventing cardiovascular disease. The findings suggest that patients who need these medications should feel more confident about continuing their treatment while working closely with their healthcare providers.
If you care about heart health, please read studies that vitamin K helps cut heart disease risk by a third, and a year of exercise reversed worrisome heart failure.
For more health information, please see recent studies about supplements that could help prevent heart disease, stroke, and results showing this food ingredient may strongly increase heart disease death risk.
Copyright © 2026 Knowridge Science Report. All rights reserved.
